Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AEye (LIDRW) Research & Development (2020 - 2025)

AEye has reported Research & Development over the past 6 years, most recently at $3.7 million for Q4 2025.

  • For Q4 2025, Research & Development fell 12.61% year-over-year to $3.7 million; the TTM value through Dec 2025 reached $13.9 million, down 14.96%, while the annual FY2025 figure was $13.9 million, 14.96% down from the prior year.
  • Research & Development for Q4 2025 was $3.7 million at AEye, up from $3.1 million in the prior quarter.
  • Over five years, Research & Development peaked at $10.8 million in Q2 2022 and troughed at $3.1 million in Q3 2025.
  • A 5-year average of $6.0 million and a median of $5.7 million in 2021 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: skyrocketed 130.0% in 2021 and later crashed 52.0% in 2024.
  • Year by year, Research & Development stood at $7.5 million in 2021, then increased by 24.25% to $9.3 million in 2022, then tumbled by 44.53% to $5.2 million in 2023, then dropped by 17.88% to $4.3 million in 2024, then dropped by 12.61% to $3.7 million in 2025.
  • Business Quant data shows Research & Development for LIDRW at $3.7 million in Q4 2025, $3.1 million in Q3 2025, and $3.7 million in Q2 2025.